GlaxoSmithKline CEO Andrew Witty Discusses Drug Prices, Disease Outbreak Preparedness
News Summary
New York Times: The Pharma CEO Who Wants to Lower Drug Prices Andrew Witty, chief executive of GlaxoSmithKline (GSK) “…In a recent interview, Andrew Witty, the chief executive of GlaxoSmithKline, who is retiring in March, talked about prices, epidemics, and other health issues. … [Witty:] We’ve been hearing from our…